×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Pediatric Therapeutic Development: From Policy to Portfolios to Patients
Session Chair(s)
Timothy R. Franson, MD
Chief Medical Officer
YourEncore , United States
This forum will examine the need for and challenges surrounding pediatric therapeutic development, and explore how policy makers, life science companies, and patient groups can work together to advance the development of pediatric therapies.
Learning Objective : Discuss the unique challenges and opportunities associated with the development of therapies for pediatric populations; Identify actionable steps to enhance and translate policy changes into advances in drug development and pediatric trials; Describe how stakeholders can work together to improve delivery to, and involvement of, patients.
Speaker(s)
Panelist
Michelle Taylor McMurry-Heath, MD, PhD
BIO, United States
President and CEO
Panelist
Stephen P. Spielberg, MD, PhD
DIA, United States
Editor-in-Chief
Panelist
Debra Lappin, JD
FaegreBD Consulting, United States
Head, Health Biosciences Practice
Have an account?
Ways to register
Registration override should work.